SynthesisBMC cardiovascular disorders2024

Efficacy and safety of inclisiran versus PCSK9 inhibitor versus statin plus ezetimibe therapy in hyperlipidemia: a systematic review and network meta-analysis.

Shengxuan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.